Mónica Gozalo

1.9k total citations
6 papers, 280 citations indexed

About

Mónica Gozalo is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Mónica Gozalo has authored 6 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 3 papers in Epidemiology and 2 papers in Clinical Biochemistry. Recurrent topics in Mónica Gozalo's work include SARS-CoV-2 and COVID-19 Research (2 papers), Antibiotic Resistance in Bacteria (2 papers) and Bacterial Identification and Susceptibility Testing (2 papers). Mónica Gozalo is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (2 papers), Antibiotic Resistance in Bacteria (2 papers) and Bacterial Identification and Susceptibility Testing (2 papers). Mónica Gozalo collaborates with scholars based in Spain. Mónica Gozalo's co-authors include Jesús Rodríguez‐Baño, Esther Calbo, Vicente Pintado, Natividad Benito, Evelyn Shaw, B. Padilla, Juan Pablo Horcajada, Virginia Pomar, Fé Tubau and Ana Laura Ortega Granados and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Clinical Microbiology and Infection and Journal of Infection.

In The Last Decade

Mónica Gozalo

6 papers receiving 274 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mónica Gozalo Spain 4 184 112 80 57 54 6 280
Yuag-Meng Liu Taiwan 8 193 1.0× 131 1.2× 89 1.1× 75 1.3× 68 1.3× 8 358
Ianick Souto Martins Brazil 12 224 1.2× 118 1.1× 64 0.8× 76 1.3× 82 1.5× 29 385
М В Сухорукова Russia 9 209 1.1× 105 0.9× 81 1.0× 67 1.2× 48 0.9× 29 323
Christopher Blunden United States 5 172 0.9× 64 0.6× 93 1.2× 40 0.7× 74 1.4× 7 240
Evangelos Vryonis Greece 7 190 1.0× 80 0.7× 67 0.8× 59 1.0× 100 1.9× 11 300
M.E. Cano Spain 8 266 1.4× 140 1.3× 71 0.9× 88 1.5× 100 1.9× 9 358
Islam M. Ghazi United States 10 197 1.1× 96 0.9× 101 1.3× 41 0.7× 129 2.4× 35 320
Milva Ballardini Italy 7 245 1.3× 116 1.0× 78 1.0× 46 0.8× 123 2.3× 9 399
Özgen Köseoğlu Eser Türkiye 9 184 1.0× 66 0.6× 49 0.6× 80 1.4× 43 0.8× 24 267
Manuela Aguilar Spain 5 181 1.0× 69 0.6× 107 1.3× 34 0.6× 77 1.4× 5 266

Countries citing papers authored by Mónica Gozalo

Since Specialization
Citations

This map shows the geographic impact of Mónica Gozalo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mónica Gozalo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mónica Gozalo more than expected).

Fields of papers citing papers by Mónica Gozalo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mónica Gozalo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mónica Gozalo. The network helps show where Mónica Gozalo may publish in the future.

Co-authorship network of co-authors of Mónica Gozalo

This figure shows the co-authorship network connecting the top 25 collaborators of Mónica Gozalo. A scholar is included among the top collaborators of Mónica Gozalo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mónica Gozalo. Mónica Gozalo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Ruiz, Raúl, Daniel Pablo‐Marcos, Mónica Gozalo, et al.. (2024). Rapid and Accurate Detection of the SARS-CoV-2 Omicron Variant with a CRISPR-Cas12a Reaction in the RT-qPCR Pot. ACS Omega. 9(16). 18046–18050. 2 indexed citations
2.
García‐Fernández, Sergio, Daniel Pablo‐Marcos, Mónica Gozalo, et al.. (2022). Evaluation of the rapid antigen detection test STANDARD F COVID-19 Ag FIA for diagnosing SARS-CoV-2: experience from an Emergency Department. Diagnostic Microbiology and Infectious Disease. 103(2). 115683–115683. 6 indexed citations
3.
Pablo‐Marcos, Daniel, Ana Rodrı́guez, Mónica Gozalo, et al.. (2020). Description of Influenza B in seasonal epidemic in Cantabria during the beginning of the pandemia due to SARS-CoV-2. Revista Española de Quimioterapia. 33(6). 444–447. 1 indexed citations
4.
Horcajada, Juan Pablo, Evelyn Shaw, B. Padilla, et al.. (2012). Healthcare-associated, community-acquired and hospital-acquired bacteraemic urinary tract infections in hospitalized patients: a prospective multicentre cohort study in the era of antimicrobial resistance. Clinical Microbiology and Infection. 19(10). 962–968. 105 indexed citations
5.
Peña, Carmen, Cristina Suárez, Mónica Gozalo, et al.. (2011). Prospective Multicenter Study of the Impact of Carbapenem Resistance on Mortality in Pseudomonas aeruginosa Bloodstream Infections. Antimicrobial Agents and Chemotherapy. 56(3). 1265–1272. 121 indexed citations
6.
Rodríguez‐Baño, Jesús, Elisenda Miró, Alicia Coelho, et al.. (2011). Colonisation and infection due to Enterobacteriaceae producing plasmid-mediated AmpC β-lactamases. Journal of Infection. 64(2). 176–183. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026